Header Logo

Connection

SALIM CHERIYAN to Carcinoma, Transitional Cell

Back to Details
This is a "connection" page, showing publications SALIM CHERIYAN has written about Carcinoma, Transitional Cell.
SALIM CHERIYAN
Connection Strength
0.171
Carcinoma, Transitional Cell
  1. Comparative analysis of three vs. four cycles of neoadjuvant gemcitabine and cisplatin for muscle invasive bladder cancer. Urol Oncol. 2022 10; 40(10):453.e19-453.e26.
    View in: PubMed
    Score: 0.171
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.